Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

RANI THERAPEUTICS HOLDINGS, INC.

(RANI)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Rani Therapeutics : BTIG Starts Rani Therapeutics Holdings at Buy With $24 Price Target

08/25/2021 | 08:08am EST


ę MT Newswires 2021
All news about RANI THERAPEUTICS HOLDINGS, INC.
11/16RANI THERAPEUTICS : Reports Third Quarter 2021 Financial Results, Provides Corporate Updat..
PU
11/16RANI THERAPEUTICS HOLDINGS, INC. Management's Discussion and Analysis of Financial Con..
AQ
11/15Rani Therapeutics Reports Third Quarter 2021 Financial Results, Provides Corporate Upda..
GL
11/15Rani Therapeutics Reports Third Quarter 2021 Financial Results, Provides Corporate Upda..
GL
11/12RANI THERAPEUTICS HOLDINGS, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
11/12Rani Therapeutics Appoints Lyn Baranowski to Board of Directors
AQ
11/12Rani Therapeutics Holdings, Inc. Appoints Lyn Baranowski to Board of Directors
CI
11/10Rani Therapeutics to Participate in a Fireside Chat at the Stifel 2021 Virtual Healthca..
AQ
09/29RANI THERAPEUTICS HOLDINGS, INC. : Regulation FD Disclosure, Financial Statements and Exhi..
AQ
09/23Rani Therapeutics to Present at Cantor Fitzgerald Virtual Global Healthcare Conference
GL
More news
Analyst Recommendations on RANI THERAPEUTICS HOLDINGS, INC.
More recommendations
Financials (USD)
Sales 2021 4,44 M - -
Net income 2021 -55,3 M - -
Net Debt 2021 - - -
P/E ratio 2021 -28,0x
Yield 2021 -
Capitalization 606 M 606 M -
Capi. / Sales 2021 137x
Capi. / Sales 2022 1 212x
Nbr of Employees 91
Free-Float 9,27%
Chart RANI THERAPEUTICS HOLDINGS, INC.
Duration : Period :
Rani Therapeutics Holdings, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends RANI THERAPEUTICS HOLDINGS, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 30,75 $
Average target price 26,60 $
Spread / Average Target -13,5%
EPS Revisions
Managers and Directors
Talat Imran Chief Executive Officer & Director
Svai S. Sanford Chief Financial Officer
Mir A. Imran Executive Chairman
Mir Hashim Chief Scientific Officer
Dennis Arthur Ausiello Independent Director
Sector and Competitors
1st jan.Capi. (M$)
RANI THERAPEUTICS HOLDINGS, INC.0.00%606
MODERNA, INC.215.53%133 648
LONZA GROUP AG29.85%59 443
IQVIA HOLDINGS INC.46.26%50 064
SEAGEN INC.-3.22%30 994
CELLTRION, INC.-40.39%24 431